Compound Evidence File
#EC-2026-0990
S-23 Raw
Filed under Raw Materials. The bureau holds 101 laboratory returns for this compound from 34 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
34 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 10.0 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 9.9 | 10.0 | 3 Apr 2026 | 4 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 4 Jan 2026 | 19 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Nov 2025 | 20 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 10.0 | 10.0 | 1 Feb 2026 | 12 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 26 Mar 2026 | 28 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 14 Jan 2026 | 7 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 10.0 | 10.0 | 10.0 | 3 Dec 2025 | 16 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 3 Feb 2026 | 12 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 6 Nov 2025 | 14 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 9.9 | 10 Jan 2026 | 3 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 10.0 | 11 Nov 2025 | 3 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 10.0 | 11 Jan 2026 | 22 May 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 9.9 | 5 May 2026 | 23 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 2 | 9.3 | 8.6 | 10.0 | 23 May 2026 | 23 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.6 | 7.7 | 10.0 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 6 | 8.4 | 7.2 | 9.7 | 23 May 2026 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.3 | 6.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 7.8 | 6.7 | 9.0 | 24 May 2026 | 24 May 2026 |
| Skye PeptidesCASE #VI-2026-0451 | X | 5 | 7.6 | 6.7 | 8.7 | 24 Apr 2025 | 24 May 2026 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 1 | 7.6 | 7.6 | 7.6 | 14 Jan 2025 | 14 Jan 2025 |
| Biolongevity LabsCASE #VI-2026-0442 | X | 2 | 7.5 | 7.4 | 7.5 | 17 Dec 2024 | 19 Jan 2026 |
| Nuscience PeptidesCASE #VI-2026-0554 | X | 3 | 7.3 | 4.6 | 9.5 | 27 Feb 2025 | 20 May 2026 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 7.2 | 7.2 | 7.2 | 27 Feb 2025 | 27 Feb 2025 |
| Alpha-GenCASE #VI-2026-0905 | X | 3 | 6.6 | 5.4 | 8.2 | 3 Jul 2025 | 26 Jan 2026 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 1 | 6.6 | 6.6 | 6.6 | 16 Mar 2025 | 16 Mar 2025 |
| NexaphCASE #VI-2026-0944 | X | 3 | 5.9 | 5.0 | 7.3 | 8 Jul 2025 | 26 Jan 2026 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 5.7 | 5.7 | 5.7 | 11 Jun 2025 | 11 Jun 2025 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 5.4 | 5.4 | 5.4 | 17 Dec 2024 | 17 Dec 2024 |
| Weifang Xingbei International TradeCASE #VI-2026-0766 | X | 1 | 3.1 | 3.1 | 3.1 | 2 Apr 2025 | 2 Apr 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 1.4 | 1.4 | 1.4 | 8 Jul 2025 | 8 Jul 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 0.0 | 0.0 | 0.0 | 9 Jun 2025 | 9 Jun 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 0.0 | 0.0 | 0.0 | 2 Apr 2025 | 2 Apr 2025 |
Open any subject to view the batch-level evidence for S-23 Raw alone.